CML-BP are characterized by frequent splenomegaly, significant blood or marrow basophilia, additional chromosomal abnormalities (ACA), or ABL1 mutations [3, 5, 7, 8]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.